A Pilot Feasibility and Preliminary Efficacy Study of an Electronic Decision Aid for Patients With Acute Myeloid Leukemia (AML)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Number of enrolled subjects who have completed the study
研究概览
简要总结
The purpose of this study is to test the feasibility and preliminary efficacy of a novel electronic decision aid to improve AML patients' understanding of their illness, prognosis, and treatment options.
详细描述
The purpose of this study is to test the feasibility and preliminary efficacy of a novel electronic decision aid to improve AML patients' understanding of their illness, prognosis, and treatment options. The objective of our program of research is to ultimately improve understanding about what patients with Acute Myeloid Leukemia (AML) know and understand about their disease, as well as what kind of information AML patients want or need to further inform them about the treatment decisions they face.
The AML Decision Aid tool consists of ten video modules, approximately 3 minutes each, containing content regarding key areas such as an explanation of what AML is, treatment choices, and things to consider when determining a treatment path. Recruited subjects will complete a series of surveys, both before viewing of the videos and after
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •At least age 18
- •Capacity to give consent
- •Diagnosis of acute myeloid leukemia (AML)
- •Fluent in English
- •Receiving care at Duke, and fits into one of the following scenarios:
- •has not yet made a treatment decision (in the DCI clinics or on the inpatient wards),
- •have recently made a decision (in the last 6 weeks), and are admitted for chemotherapy on 9100 or in the oncology treatment center to receive outpatient therapy,
- •or, during remission, while receiving consolidation chemotherapy in the hospital
排除标准
- •Patients too sick to participate per clinician discretion
结局指标
主要结局
Number of enrolled subjects who have completed the study
时间窗: 1 day
Feasibility will be determined by enrolled subjects who complete the study (including watching all videos, and completing the surveys).
次要结局
- Change in knowledge about AML after video viewing(Day 1. Pre-video screening and post-video)